These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 21619669

  • 1. Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
    Brenu EW, van Driel ML, Staines DR, Ashton KJ, Ramos SB, Keane J, Klimas NG, Marshall-Gradisnik SM.
    J Transl Med; 2011 May 28; 9():81. PubMed ID: 21619669
    [Abstract] [Full Text] [Related]

  • 2. Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
    Hardcastle SL, Brenu EW, Johnston S, Nguyen T, Huth T, Wong N, Ramos S, Staines D, Marshall-Gradisnik S.
    BMC Immunol; 2015 Jun 02; 16():35. PubMed ID: 26032326
    [Abstract] [Full Text] [Related]

  • 3. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Huth TK, Staines D, Marshall-Gradisnik S.
    J Transl Med; 2016 Apr 21; 14():97. PubMed ID: 27098723
    [Abstract] [Full Text] [Related]

  • 4. Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Hardcastle SL, Brenu EW, Johnston S, Nguyen T, Huth T, Ramos S, Staines D, Marshall-Gradisnik S.
    J Transl Med; 2015 Sep 14; 13():299. PubMed ID: 26370228
    [Abstract] [Full Text] [Related]

  • 5. Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Rivas JL, Palencia T, Fernández G, García M.
    Front Immunol; 2018 Sep 14; 9():1028. PubMed ID: 29867995
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis.
    Brenu EW, van Driel ML, Staines DR, Ashton KJ, Hardcastle SL, Keane J, Tajouri L, Peterson D, Ramos SB, Marshall-Gradisnik SM.
    J Transl Med; 2012 May 09; 10():88. PubMed ID: 22571715
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis.
    Huth TK, Brenu EW, Ramos S, Nguyen T, Broadley S, Staines D, Marshall-Gradisnik S.
    Scand J Immunol; 2016 Jan 09; 83(1):44-51. PubMed ID: 26381393
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Cliff JM, King EC, Lee JS, Sepúlveda N, Wolf AS, Kingdon C, Bowman E, Dockrell HM, Nacul L, Lacerda E, Riley EM.
    Front Immunol; 2019 Jan 09; 10():796. PubMed ID: 31057538
    [Abstract] [Full Text] [Related]

  • 15. Novel identification and characterisation of Transient receptor potential melastatin 3 ion channels on Natural Killer cells and B lymphocytes: effects on cell signalling in Chronic fatigue syndrome/Myalgic encephalomyelitis patients.
    Nguyen T, Staines D, Nilius B, Smith P, Marshall-Gradisnik S.
    Biol Res; 2016 May 31; 49(1):27. PubMed ID: 27245705
    [Abstract] [Full Text] [Related]

  • 16. Increased expression of activation antigens on CD8+ T lymphocytes in Myalgic Encephalomyelitis/chronic fatigue syndrome: inverse associations with lowered CD19+ expression and CD4+/CD8+ ratio, but no associations with (auto)immune, leaky gut, oxidative and nitrosative stress biomarkers.
    Maes M, Bosmans E, Kubera M.
    Neuro Endocrinol Lett; 2015 May 31; 36(5):439-46. PubMed ID: 26707044
    [Abstract] [Full Text] [Related]

  • 17. Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis.
    Brenu EW, Huth TK, Hardcastle SL, Fuller K, Kaur M, Johnston S, Ramos SB, Staines DR, Marshall-Gradisnik SM.
    Int Immunol; 2014 Apr 31; 26(4):233-42. PubMed ID: 24343819
    [Abstract] [Full Text] [Related]

  • 18. Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Cabanas H, Muraki K, Eaton N, Balinas C, Staines D, Marshall-Gradisnik S.
    Mol Med; 2018 Aug 14; 24(1):44. PubMed ID: 30134818
    [Abstract] [Full Text] [Related]

  • 19. Immunometabolic changes and potential biomarkers in CFS peripheral immune cells revealed by single-cell RNA sequencing.
    Sun Y, Zhang Z, Qiao Q, Zou Y, Wang L, Wang T, Lou B, Li G, Xu M, Wang Y, Zhang Z, Hou X, Chen L, Zhao R.
    J Transl Med; 2024 Oct 11; 22(1):925. PubMed ID: 39394558
    [Abstract] [Full Text] [Related]

  • 20. Cytotoxic lymphocyte microRNAs as prospective biomarkers for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
    Brenu EW, Ashton KJ, van Driel M, Staines DR, Peterson D, Atkinson GM, Marshall-Gradisnik SM.
    J Affect Disord; 2012 Dec 10; 141(2-3):261-9. PubMed ID: 22572093
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.